Poster Sessions 2018-09-28T10:58:43+00:00

Poster Sessions

Guided poster tour I
Guided poster tour II

Guided poster tours I

October 10, 2018 | 1:00 – 2:30 pm

P I – 1-1 The influence of purine metabolism on excitotoxic neuronal injury Joshua Kleine (Halle (Saale), GER)
P I – 1-3 Under hypoosmolar conditions substance P initiates and perpetuates waves of self-regenerating cortical spreading depolarization (CSD) in rat in vivo Frank Richter (Jena, GER)
P I – 1-4 Gene Expression Levels in Acute Large Vessel Stroke in Humans Sarah Martha (Lexington, USA)
P I – 1-5 Assessment of a potential therapeutic strategy for neuroinflammation involving moderate hypothermia and cyclosporine A in an ischemia/reperfusion murine OHSC model Sylvia Wowro (Berlin, GER)
P I – 1-6 Opposite effects of neuroprotective cannabinoids, Palmitoylethanolamide and 2-Arachidonoylglycerol on function and morphology of microglia Urszula Grabiec  (Halle (Saale), GER)
P I – 1-7 LINGO-1 directed siRNA nanoparticles promote central remyelination in ethidium bromide induced demyelination in rats Ola Saed (Alexandria, EGY)
P I – 1-8 Endothelial α6β4 integrin protects against experimental autoimmune encephalomyelitis by maintaining vascular integrity and tight junction protein expression Richard Milner (La Jolla, USA)
P I – 1-9 Influence LPS-induced inflammation to disruption blood-brain barrier in mice Katherine Astakhova (Moscow, RUS)
P II – 1-15 Pentraxin-3 is expressed in different brain cells with a specific temporal pattern after traumatic brain injury. Stefania Ippati (Italy)
P I – 2-1 The Amyloid Precursor Protein family – distinct modulators of neuronal injury Roberto Cappai (Parkville, AUS)
P I – 2-2 Rapamycin enhances mitophagy and attenuates  apoptosis and  oxidative stress after spinal ischemia-reperfusion injury Qiang Li (Shanghai, CHN)
P I – 2-3 Identification of early electrophysiological markers to predict spontaneous post stroke recovery in mice Claudia Alia (Pisa, ITA)
P I – 3-1 Stimulation of axon growth in the in vitro model of CNS injury by transgenic activation of alpha9 integrin combined with biomodified material Kristyna Kekulova (Prague, CZE)
P I – 3-2 Evaluating the brain biocompatibility of new self-assembling peptide hydrogels for therapeutic use in brain tissue engineering and regeneration after stroke Roxana Sava (Manchester, UK)
P I – 3-3 Stem Cell-Drug Interactions: An Important, but Neglected Aspect of Future Neuronal Stem Cell Therapy. A Systematic Review and Meta-analysis Maulana Ikhsan (Lübeck, GER)
P I – 3-4  Antioxidant properties of innovative polymer coated cerium oxide nanoparticles for stroke treatment Geoffroy Goujon (Paris, FRA)
P I – 3-5 Development of 3D cellular microenvironments as potential therapy for brain repair after ischemic stoke Irene Louca (Manchester, UK)
P I – 3-6 Optimising the biodistribution of mesenchymal stem cells in a preclinical mouse model of ischaemic stroke to enhance the therapeutic potential of primed mesenchymal stem cells for therapy Raymond Wong (Manchester, UK)
P I – 3-7 Microfilament-engineered midbrain organoids as a new model to study midbrain-associated neurodegenerative diseases Anna Tejchman (Cracow, POL)
P I – 3-8 Large-scale generation of transplantable induced motor neurons (iMN) from human fibroblasts facilitates functional recovery after spinal cord injury by cell therapy Hyunah Lee (Ulsan, KOR)
P I – 4-1 Ameliorative effects of Pelargonium roseum oil on spatial working memory and anxiety-like behavior induced by methomyl pesticide exposure in Wistar rats. Khene Mohammed Amine (Ghardaia, DZA)
P I – 4-2 PLCG1 is required to ensure proper chemoattraction of netrin-1/DCC signaling in developing mouse brain Du-Seock Kang (Daejeon, KOR)
P I – 4-3 Substrate elasticity induces quiescence and promotes neurogenesis of primary neural stem cells – an in vitro model of the physiological cerebral milieu Stefan Blaschke (Köln, GER)
P I – 4-4 Snack Food impacts Resting State Networks in Rodents and Humans Andrea Mendez-Torrijos (Erlangen, GER)
P I – 4-5 Impact of recurrent hypoglycemia exposure on hippocampal metabolism Kunjan Dave (Miami, USA)
P I – 4-6 Associations among inflammation, mental health, and quality of life in adults with metabolic syndrome Ji-Ryang Kim (Suwon-si, KOR)
P I – 5-1 Protein Z plasma levels in ischemic stroke patients undergoing thrombolysis: a pilot study Artur Slomka (Bydgoszcz, POL)
P I – 5-2 Inhibition of G9a sensitizes neuronal cell death via increasing DNA damage under ischemic condition SangHa Baik (Singapore, SGP)
P I – 5-3 Response to Leukemia Inhibitory Factor is dependent on age and sex in a rat model of large vessel occlusion Keith Pennypacker (Lexington, USA)
P I – 5-4 Imaging of brain reorganization after experimental stroke by repetitive two-photon microscopy Susana Valero Freitag (Munich, GER)
P I – 5-5 Age-related differences in recovery of cognitive function following stroke to the prefrontal cortex: BDNF-mediated reopening of a critical window for stroke recovery Josh Houlton (Dunedin, NZL)
P I – 5-6 Identifying Changes in Axonal Connectivity following Prefrontal Cortex Stroke in Mice: Impaired Thalamic Input. Deanna Barwick (Dunedin, NZL)
P I – 5-7 Description of a novel phosphodiesterase-3 inhibitor protecting mice from ischemic stroke independent from platelet function Michael Bieber (Würzburg, GER)
P I – 5-8 Spontaneous intracerebral haemorrhage in zebrafish larvae induces translatable pathological and immunological outcomes Siobhan Crilly (Manchester, UK)
P I – 5-9 Cell-specific regulation of autophagy in cerebral ischemia–reperfusion injury: Sec22b and Ykt6 exert as autophagosome removers in neurons Haiying Li (Suzhou, CHN)
P I – 5-10 Targeting platelet GPVI but not α2β1-mediated collagen binding contributes to ischemic stroke in mice. Michael Schuhmann (Würzburg, GER)
P I – 5-11 Atlas-based lesion mapping for in vivo MRI and ex vivo histology of stroke mice Frederique Wieters (Cologne, GER)
P I – 5-12 Ligature-induced periodontitis does not alter acute outcome or inflammation after experimental stroke in mice. Conor O’Boyle (Manchester, UK)
P I – 5-13 Inhaled nitric oxide as a modulator for vascular inflammation after experimental stroke Rebecca Sienel (Munich, GER)
P I – 5-14 The role of the extracellular matrix laminin-511 in vascular inflammation, blood-brain barrier repair and angiogenesis after stroke. Hannah Thurgur (Manchester, UK)
P I – 5-15 Role of platelets in tissue remodelling and functional recovery after experimental cerebral ischemia Friederike Langhauser (Essen, GER)
P I – 5-16 Prognostic serum markers for stroke outcome Bettina Clausen (Odense, DNK)
P I – 5-17 The choroid plexus: a road to the brain for vascular tPA Vincent Zuba (Caen, FRA)
P I – 5-18 Unravelling the (sub)cellular mechanisms of low frequency electromagnetic stimulation as ischemic stroke therapy Hannelore Kemps (Hasselt, BEL)
P I – 5-19 Non-erythropoietic EPO derivatives mediate protection in a mice model of brain ischemia/reperfusion injury through the overwhelming effect on the mitochondrial respiration Irina Mukhina (Nizhny Novgorod, RUS)
P I – 5-20 Contribution of inflammasomes to ischaemic stroke Jack Barrington (Manchester, UK)
P I – 6-1 An emerging role for Hsp27 in VCID. Brittani  Price (Lexington, USA)
P I – 6-2 Investigating metabolic regulation of the cerebrovasculature. Claire White (Manchester, UK)
P I – 6-4 Posttranslational-modifications of oligomeric amyloid beta (AβO) trigger synaptic dysfunction by their own mechanisms in Alzheimer”s disease (AD) PingAn YuanXiang (Magdeburg, GER)
P I – 6-5 MarkVCID: Vascular contributions to cognitive impairment and dementia biomarkers development and validation Tiffany Sudduth (Lexington, USA)
P I – 6-6 Neuron and astrocyte metabolic responses to the proteasome inhibitor in Alzheimer’s disease Vladimir Pershin (Nizhny Novgorod, RUS)
P I – 6-7 Bioluminescence imaging reveals neurogenesis and neuroblast migration induced by osteopontin in the mouse brain after experimental ischemia Monika Rabenstein (Cologne, GER)
P I – 6-8 Prominent vessels on quantitative susceptibility maps indicate microvascular pathology after experimental cerebral ischemia and reperfusion Markus Vaas (Zurich, CHE)
P I – 6-9 A novel automated tool for analysis of microglial morphology Steffanie Heindl (Munich, GER)
P I – 6-10 Factors affecting the biodistribution of glial progenitors transplanted in the piglet cerebral ventricular system using a 3D printed model Rohit Srivastava (Baltimore, USA)